Data / Research funding / Polycystic Kidney Disease

Polycystic Kidney Disease: 163 NIH awards ($164.7M) to 65 organizations

Name: NIH and NSF awards on Polycystic Kidney Disease
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

163 NIH awards ($164.7M) in the NIH spending category Polycystic Kidney Disease, to 65 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Polycystic Kidney Disease Watch Polycystic Kidney Disease

Topic: NIH spending category

Awards

163 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Central Coordinating Site for the Polycystic Kidney Disease (PKD) Research Core Centers	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$4,824,202	July 20, 2020	August 31, 2030	WATNICK, TERRY J	reporter.nih.gov
Maryland Polycystic Kidney Disease Research Core Center (MPKD-RCC)	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$4,654,991	August 24, 2020	August 31, 2030	WATNICK, TERRY J	reporter.nih.gov
UAB Childhood Cystic Kidney Disease Center (UAB-CCKDC)	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$4,330,298	July 20, 2020	August 31, 2030	YODER, BRADLEY K.	reporter.nih.gov
In vivo Pathway Discovery in Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$3,867,356	September 9, 2019	June 30, 2025	SOMLO, STEFAN	reporter.nih.gov
ADPKD: Disease Spectrum & Genotype-Phenotype Correlations	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$3,092,802	August 1, 2001	May 31, 2028	HARRIS, PETER C.	reporter.nih.gov
Novel role of urinary urate in renal cystogenesis and water regulation	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$2,967,657	September 1, 2025	August 31, 2029	CHEBIB, FOUAD T	reporter.nih.gov
Investigation of common disease mechanisms in nonsyndromic and syndromic PKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,712,900	April 15, 2002	December 31, 2026	HARRIS, PETER C.	reporter.nih.gov
Biomechanical drivers of cystogenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$2,696,798	September 24, 2021	July 31, 2025	GUSELLA, GABRIELE LUCA	reporter.nih.gov
Daily Caloric Restriction in Overweight and Obese Adults with ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,687,567	July 1, 2021	May 31, 2027	NOWAK, KRISTEN LYNN	reporter.nih.gov
A comprehensive map of polycystin channel regulation and its implications in polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$2,672,628	September 15, 2021	July 31, 2025	DELLING, MARKUS G	reporter.nih.gov
Cell polarity and morphogenesis in Xenopus embryos	NIH	National Institute of General Medical Sciences	2021 to 2025	$2,595,273	August 1, 2017	June 30, 2027	SOKOL, SERGEI	reporter.nih.gov
Polycystins, cilia, and extracellular vesicles in C. elegans	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,467,492	May 1, 2001	June 30, 2027	BARR, MAUREEN M	reporter.nih.gov
Role of homocysteine metabolism, endothelial function and microvascular rarefaction on renal disease severity and progression in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$2,449,537	May 1, 2021	March 31, 2026	IRAZABAL, MARIA V	reporter.nih.gov
PKD proteins in endothelial cells	NIH	National Heart, Lung, and Blood Institute	2021 to 2024	$2,397,306	February 15, 2021	January 31, 2026	JAGGAR, JONATHAN H	reporter.nih.gov
Role of primary cilium-generated signaling in polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$2,373,193	January 15, 2022	November 30, 2026	MUKHOPADHYAY, SAIKAT	reporter.nih.gov
Intraflagellar Transport Proteins in Mice	NIH	National Institute of General Medical Sciences	2021 to 2025	$2,358,960	June 1, 2001	January 31, 2027	PAZOUR, GREGORY J	reporter.nih.gov
Kidney Stone Disease In ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,353,533	September 22, 2021	June 30, 2027	CHONCHOL, MICHEL BENJAMIN	reporter.nih.gov
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems	NIH	National Center for Advancing Translational Sciences	2022 to 2024	$2,334,876	July 15, 2020	June 30, 2026	FREEDMAN, BENJAMIN SOLOMON	reporter.nih.gov
Modulation of cystogenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$2,324,556	May 1, 2022	February 28, 2027	ZHOU, JING	reporter.nih.gov
NPHP2 in ciliary function, renal fibrosis and cyst formation	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,168,386	September 15, 2017	April 30, 2027	SUN, ZHAOXIA	reporter.nih.gov
PKD1 derepression as a potential therapy for Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$2,160,777	September 1, 2022	May 31, 2027	PATEL, VISHAL	reporter.nih.gov
Ion Channel Function and Regulation of the Polycystin-1/2 Complex in Kidney Physiology and Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$2,154,216	July 1, 2020	May 31, 2026	QIAN, FENG	reporter.nih.gov
Dissecting and targeting lysosomal signaling in kidney tumorigenesis	NIH	National Cancer Institute	2022 to 2025	$2,144,296	March 21, 2022	February 28, 2027	ZONCU, ROBERTO	reporter.nih.gov
Nephronophthisis-related ciliopathies and ciliary specialization	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,071,959	February 15, 2023	December 31, 2026	BARR, MAUREEN M	reporter.nih.gov
Molecular Mechanisms Regulating Epithelial Cell Apical Polarity and Ciliogenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$2,046,879	January 15, 2004	June 30, 2028	PREKERIS, RYTIS	reporter.nih.gov
Identification of new therapeutic targets for ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$2,012,444	September 1, 2021	June 30, 2025	SKOLNIK, EDWARD Y	reporter.nih.gov
Injury Response Mediated Pathogenesis in Renal Ciliopathies	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$1,950,967	February 1, 2023	November 30, 2026	YODER, BRADLEY K.	reporter.nih.gov
The crosstalk of DNA and lysine methyltransferases in ADPKD.	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,917,952	September 15, 2020	July 31, 2026	LI, XIAOGANG	reporter.nih.gov
ADPKD: Understanding immunosuppression mechanisms and discovering treatment	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,841,779	September 1, 2021	June 30, 2025	LI, XIAOGANG	reporter.nih.gov
Molecular and cellular basis of the renal diseases associated with Alagille Syndrome	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$1,811,392	May 1, 2021	February 28, 2027	SURENDRAN, KAMESWARAN	reporter.nih.gov
Ketosis as a therapy for polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,790,657	April 1, 2020	January 31, 2026	WEIMBS, THOMAS	reporter.nih.gov
Regulation of Kidney-Specific Gene Expression	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$1,731,451	November 18, 2022	June 30, 2027	IGARASHI, PETER	reporter.nih.gov
The impact of RNA chemical modifications on polycystic kidney disease progression	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,686,633	May 11, 2015	December 31, 2025	PATEL, VISHAL	reporter.nih.gov
Impact of Phosphaturia on Renal Osteopontin Production and PKD Progression	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,647,056	September 23, 2021	July 31, 2025	STUBBS, JASON	reporter.nih.gov
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease	NIH	National Heart, Lung, and Blood Institute	2022 to 2025	$1,615,000	May 15, 2022	April 30, 2027	ALTAMIRANO, FRANCISCO	reporter.nih.gov
Cilia calcium dysregulation in polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$1,592,249	September 1, 2022	May 31, 2027	DECAEN, PAUL GREGORY	reporter.nih.gov
Pannexin-1/P2X7 interaction promotes excessive ATP release in kidney cysts and ADPKD progression via reduced NaCl reabsorption	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,581,990	June 3, 2021	April 30, 2026	PAVLOV, TENGIS S	reporter.nih.gov
Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis Complex	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2025	$1,569,410	April 5, 2023	March 31, 2028	HENSKE, ELIZABETH P	reporter.nih.gov
Molecular Basis of Hair Cell Stereocilia Bundle Morphology	NIH	National Institute on Deafness and Other Communication Disorders	2021 to 2022	$1,559,148	August 1, 2018	July 31, 2024	INDZHYKULIAN, ARTUR	reporter.nih.gov
Decoding reno-protective mechanisms in mouse Pkhd1 models: Implications for ARPKD therapeutics	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,555,092	July 1, 2020	April 30, 2026	CALDOVIC, LJUBICA MORIZONO	reporter.nih.gov
Dissecting the Diverse Roles of Importin α at the Plasma Membrane	NIH	National Institute of General Medical Sciences	2022 to 2025	$1,554,644	August 1, 2022	July 31, 2027	BROWNLEE, CHRISTOPHER WILLIAM	reporter.nih.gov
Molecular dissection of the ciliary gate	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$1,550,746	August 15, 2014	November 30, 2028	HU, JINGHUA	reporter.nih.gov
Imaging Assessments of ARPKD Kidney Disease Progression	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2025	$1,546,644	August 20, 2019	February 28, 2029	DELL, KATHERINE MACRAE	reporter.nih.gov
Cross talk between epithelial, inflammatory and mesenchymal cells in the development of portal fibrosis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,522,465	May 1, 2015	August 31, 2024	STRAZZABOSCO, MARIO	reporter.nih.gov
Developing a New Therapeutic Approach for Autosomal Dominant Polycystic Kidney Disease.	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,426,590	July 1, 2020	May 31, 2026	CEBOTARU, LIUDMILA	reporter.nih.gov
Extracellular protease modulation of the cilium transition zone in kidney development and disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$1,422,410	January 1, 2022	December 31, 2026	NANDADASA, SUMEDA	reporter.nih.gov
Polycystin Dependent Mechanisms of Tubular Plasticity	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,420,815	September 1, 2019	June 30, 2025	SOMLO, STEFAN	reporter.nih.gov
Ciliary Disassembly, a modifier of Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,410,976	March 15, 2021	January 31, 2026	TSIOKAS, LEONIDAS	reporter.nih.gov
Pathogenic reciprocal interplay between cyst epithelium and myofibroblasts in polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2025	$1,405,970	February 1, 2023	November 30, 2026	RAO, REENA	reporter.nih.gov
Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$1,370,843	August 15, 2024	May 31, 2029	NOWAK, KRISTEN LYNN	reporter.nih.gov
Structural Mechanisms of Polycystic Kidney Disease Proteins	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$1,348,334	July 22, 2024	April 30, 2028	CAO, ERHU	reporter.nih.gov
Kidney Tubular Damage and Dysfunction in Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$1,339,274	June 1, 2024	March 31, 2028	GARIMELLA, PRANAV	reporter.nih.gov
Molecular modulators of polycystin signaling	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,338,874	March 1, 2019	January 31, 2025	SOMLO, STEFAN	reporter.nih.gov
Human-specific Abnormal Alternative Splicing of the Wild-type PKD1 Gene Induces Premature Termination of Polycystin-1	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2024	$1,332,936	September 15, 2020	July 31, 2025	WARD, CHRISTOPHER J	reporter.nih.gov
Screening for modifiers of PKD severity using ENU Mutagenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$1,263,682	September 19, 2018	July 31, 2024	BEIER, DAVID R.	reporter.nih.gov
Targeting kidney resident macrophage niche filling to slow cystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$1,256,183	September 15, 2022	June 30, 2027	ZIMMERMAN, KURT A	reporter.nih.gov
The mechanism of cell size regulation by polycystins	NIH	National Institute of General Medical Sciences	2022 to 2025	$1,254,880	April 15, 2022	March 31, 2027	CHEN, QIAN	reporter.nih.gov
Tissue Chip Data to the Microphysiology Systems Database (MPS-Db) Supplement to A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing	NIH	National Center for Advancing Translational Sciences	2021	$1,250,569	July 25, 2017	June 30, 2023	HIMMELFARB, JONATHAN	reporter.nih.gov
Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseases	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2025	$1,219,151	December 18, 2023	June 30, 2027	DAI, DAO-FU	reporter.nih.gov
Modeling genetic contributions to biliary atresia	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$1,197,376	June 15, 2023	April 30, 2027	KARPEN, SAUL J.	reporter.nih.gov
Transition zone control of ciliary signaling	NIH	National Institute of Dental & Craniofacial Research	2021 to 2022	$1,184,783	July 18, 2011	August 31, 2023	REITER, JEREMY F	reporter.nih.gov
The Role of Wheat-Gluten in Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$1,175,661	September 21, 2022	June 30, 2027	SAIGUSA, TAKAMITSU	reporter.nih.gov
Molecular dysregulation of primary cilia TRPP2 channels caused by Finger 1 variants	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,136,005	September 3, 2019	July 31, 2024	DECAEN, PAUL GREGORY	reporter.nih.gov
Pathobiology of Hepatic Epithelia	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,073,250	December 1, 1978	March 31, 2024	LARUSSO, NICHOLAS F.	reporter.nih.gov
Functional characterization of a novel key regulator of the distal nephron whose deficiency leads to renal fibrosis and cyst formation	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,049,616	December 17, 2018	November 30, 2024	MARNEROS, ALEXANDER GEORG	reporter.nih.gov
Trafficking and Sorting Mechanisms of Golgi Vesicles to Cilia	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,043,820	July 1, 2020	April 30, 2025	TAKEMARU, KEN-ICHI	reporter.nih.gov
Investigate the trafficking and function of polycystins in primary cilia and their implications for polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$1,032,322	April 1, 2024	January 31, 2028	LING, KUN	reporter.nih.gov
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model Disease	NIH	National Center for Advancing Translational Sciences	2021	$1,006,126	July 25, 2017	June 30, 2024	BONVENTRE, JOSEPH VINCENT	reporter.nih.gov
Understanding Polycystin-1 Structure-GPCR Function for the Development of New Therapeutic Approaches in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$1,000,938	January 15, 2020	November 30, 2024	MASER, ROBIN LEE	reporter.nih.gov
Cyst induction and growth in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$981,736	August 15, 2024	May 31, 2029	CEBRIAN LIGERO, CRISTINA	reporter.nih.gov
Differentiating slow from rapidly progressive ADPKD by cell-specific mitochondrial and transcriptional profiles	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$981,084	April 1, 2024	January 31, 2029	LASSEIGNE, BRITTANY NICOLE	reporter.nih.gov
Role of FBW7 in cystic diseases of the kidney	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$973,272	August 15, 2024	May 31, 2028	TSIOKAS, LEONIDAS	reporter.nih.gov
Pattern formation and function of PKD2/polycystin-2 in motile cilia	NIH	National Institute of General Medical Sciences	2021 to 2023	$906,000	September 18, 2020	July 31, 2024	LECHTRECK, KARL	reporter.nih.gov
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems	NIH	National Center for Advancing Translational Sciences	2021	$875,910	July 15, 2020	July 31, 2022	HIMMELFARB, JONATHAN	reporter.nih.gov
Feasibility study of empagliflozin in patients with autosomal dominant polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2024	$874,309	August 15, 2022	July 31, 2025	CHONCHOL, MICHEL BENJAMIN	reporter.nih.gov
In vivo investigation of PKD1 upstream open reading frames as a therapeutic target in autosomal dominant polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$853,472	December 15, 2023	November 30, 2028	BESSE, WHITNEY ELISE	reporter.nih.gov
Targeting Myosin to Treat Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$839,264	April 12, 2023	June 30, 2028	FREEDMAN, BENJAMIN SOLOMON	reporter.nih.gov
A Model for Human Liver Fibrosis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022	$772,327	September 1, 2022	August 31, 2025	PELTZ, GARY A	reporter.nih.gov
Defective flow-dependent tubule transport in the pathogenesis of kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$754,089	February 1, 2019	November 30, 2023	WANG, TONG WANG	reporter.nih.gov
QSM for detection of hemorrhaging cysts and risk stratification in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$728,513	January 20, 2025	November 30, 2029	DIMOV, ALEXEY	reporter.nih.gov
A Human Organoid Model of Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$706,000	September 15, 2018	June 30, 2023	FREEDMAN, BENJAMIN SOLOMON	reporter.nih.gov
Genetic dissection of ciliary ARL13B in kidney cystogenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2024	$688,325	September 15, 2022	June 30, 2025	CASPARY, TAMARA J.	reporter.nih.gov
AKAP Modulation of Renal Signaling	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$681,874	July 1, 2019	May 31, 2024	SCOTT, JOHN D	reporter.nih.gov
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) IV: Prognosis for End-Stage Renal Disease and Biomarker Validation	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$674,302	April 1, 2017	March 30, 2023	YU, ALAN S	reporter.nih.gov
Polycystin-1 C terminal tail cleavage: Mechanisms and meaning	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$640,001	January 1, 2025	November 30, 2028	CAPLAN, MICHAEL J.	reporter.nih.gov
Mechanisms of Signaling Protein Retention in the Primary Cilium	NIH	National Institute of General Medical Sciences	2021 to 2022	$626,000	May 24, 2019	March 31, 2024	JIANG, YU	reporter.nih.gov
Regulation of Kidney-Specific Gene Expression	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$623,434	April 15, 1991	March 31, 2023	IGARASHI, PETER	reporter.nih.gov
Molecular genetic bases of polycystic and tubulointerstitial kidney diseases	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$601,785	June 1, 2019	October 31, 2024	BESSE, WHITNEY ELISE	reporter.nih.gov
Renal Denervation to Treat Polycystic Kidney Disease: Mechanisms and Mediators	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024	$600,159	December 15, 2023	November 30, 2024	BANEK, CHRISTOPHER T	reporter.nih.gov
Renal Denervation to Treat Polycystic Kidney Disease: Mechanisms and Mediators	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$594,574	November 1, 2024	November 30, 2028	BANEK, CHRISTOPHER T	reporter.nih.gov
CDKN1A (p21) regulation of cyst growth	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$587,212	January 1, 2025	November 30, 2028	YODER, BRADLEY K.	reporter.nih.gov
Understanding the physiology and pathophysiology of kidney-derived vasopressin	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2025	$537,861	April 1, 2023	March 31, 2028	ARROYO ORNELAS, JUAN PABLO	reporter.nih.gov
Investigating intracellular cholesterol biosynthesis as a regulator of polycystic kidney disease progression	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$504,621	January 1, 2025	November 30, 2029	LAKHIA, RONAK	reporter.nih.gov
High Urinary Phosphate Induces TLR4-mediated Inflammation and Cystogenesis in Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$469,500	July 15, 2023	July 14, 2026	ZHANG, YAN	reporter.nih.gov
Investigation of urinary extracellular vesicles as novel and safe therapeutics for autosomal recessive polycystic kidney disease	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023	$465,690	September 4, 2023	August 31, 2025	CHUNG, EUN JI PAIGE	reporter.nih.gov
Investigating CD4 T regulatory cells during rapid cystogenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$454,992	May 1, 2020	April 30, 2025	ZIMMERMAN, KURT A	reporter.nih.gov
Theory of Solute and Water Transport Across Epithelia	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$423,750	June 19, 2018	June 30, 2024	WEINSTEIN, ALAN M	reporter.nih.gov
Noninvasive evaluation of the intrarenal microvasculature in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$418,971	August 1, 2021	June 30, 2025	IRAZABAL, MARIA V	reporter.nih.gov
CYTOSKELETAL AND SIGNALING MECHANISMS REGULATING CILIARY TRAFFIC	NIH	National Institute of General Medical Sciences	2021	$410,000	September 1, 2018	August 31, 2023	AVASTHI, PRACHEE	reporter.nih.gov
Generate Zebrafish Conditional Knockout Model for Ciliopathy Research	NIH	Office of the Director, National Institutes of Health	2021 to 2022	$408,375	July 15, 2021	May 31, 2025	PARANT, JOHN M	reporter.nih.gov
Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseases	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022	$396,609	September 15, 2022	June 30, 2027	DAI, DAO-FU	reporter.nih.gov
Novel signaling pathways in the ciliary inversin compartment	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$393,120	February 1, 2020	June 30, 2022	CZARNECKI, PETER G	reporter.nih.gov
The Molecular Mechanisms of Polycystin-1 Proteolytic Cleavage in Kidney Health and Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$380,777	September 15, 2017	May 31, 2024	QIAN, FENG	reporter.nih.gov
Ultrasound-programmable gene editing in kidneys	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$379,212	September 24, 2021	August 31, 2024	MEDINA, SCOTT HAMMOND	reporter.nih.gov
NBCe1-mediated Regulation of HCO3- is a Novel Mechanism Underlying Metabolic Reprogramming and Cystogenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$369,035	March 30, 2022	March 29, 2027	BROWN, MATTHEW	reporter.nih.gov
High-throughput dissection of transcriptional regulation in kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2025	$354,621	September 1, 2022	August 31, 2026	TYCKO, JOSH	reporter.nih.gov
Arginine-Polyamine Pathway Inhibitor for Treatment of ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$349,325	August 1, 2025	July 31, 2027	VITEK, MICHAEL PETER	reporter.nih.gov
Cellular tools for studying PKD1 regulation in autosomal dominant polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$342,002	September 15, 2025	August 31, 2027	LARSON, ERIK	reporter.nih.gov
Defining the functional role of T-cells in Autosomal Dominant Polycystic Kidney Disease pathology	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$335,804	August 1, 2018	July 31, 2024	HOPP, KATHARINA	reporter.nih.gov
Novel signaling pathways in the ciliary inversin compartment	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2024	$328,968	February 1, 2020	December 31, 2024	CZARNECKI, PETER G	reporter.nih.gov
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$325,000	September 19, 2023	August 31, 2025	MAXIM, DEMETRIOS S	reporter.nih.gov
Design of Calcium-sensing Receptor Targeted Thera(g)nostic Agents	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024	$323,743	September 1, 2024	August 31, 2025	YANG, JENNY J.	reporter.nih.gov
Polycystin activators as novel therapeutic approach for ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$323,000	July 1, 2021	June 30, 2023	DELLING, MARKUS G	reporter.nih.gov
The Role of Peroxisome Proliferator Activated Receptor Alpha in Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$319,680	July 1, 2018	April 30, 2024	LAKHIA, RONAK	reporter.nih.gov
Targeting Myosin to Treat Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$298,326	April 12, 2023	March 31, 2025	FU, HONGXIA	reporter.nih.gov
The Role of Fibronectin in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$285,230	September 20, 2019	July 31, 2022	KREIDBERG, JORDAN A	reporter.nih.gov
Multi-parametric MRI of ARPKD liver disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$252,386	April 1, 2021	February 28, 2025	HARTUNG, ERUM AFTAB	reporter.nih.gov
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.	NIH	National Institute on Aging	2023	$249,658	September 30, 2023	August 31, 2025	QUARLES, L DARRYL	reporter.nih.gov
Therapeutic rescue of Polycystin-1 protein expression by targeting PKD1 upstream open reading frames	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2024	$246,225	March 1, 2023	February 28, 2025	BESSE, WHITNEY ELISE	reporter.nih.gov
Measuring metabolically active kidney tissue in autosomal dominant polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$242,061	August 1, 2021	July 31, 2023	BJORNSTAD, PETTER	reporter.nih.gov
High-throughput Flow Culture of 3D Human PKD Models for Therapeutic Screening	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$234,978	May 15, 2023	May 14, 2025	LIN, NEIL	reporter.nih.gov
Complement as a modulator of immunosuppression and progression in Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$233,250	August 1, 2021	June 30, 2024	HOPP, KATHARINA	reporter.nih.gov
Comprehensive Analysis of Polycystin Related Endothelial Cell Signaling Pathways	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$228,166	September 30, 2012	March 31, 2024	WATNICK, TERRY J	reporter.nih.gov
Deciphering the role of long noncoding RNA Pvt1 in preclinical models of ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$227,288	December 15, 2023	November 30, 2025	ABOUDEHEN, KARAM	reporter.nih.gov
Deregulation of Long Noncoding RNA in the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$217,054	May 15, 2019	October 31, 2022	ABOUDEHEN, KARAM	reporter.nih.gov
The critical ciliary role of ARL13B in kidney cystogenesis	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2023	$216,849	September 30, 2020	August 31, 2024	VAN SCIVER, ROBERT E	reporter.nih.gov
Development of a fluidic chip model of PKD to elucidate cystogenic signals using kidney organoids	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022	$215,628	September 15, 2022	September 14, 2024	MORIZANE, RYUJI	reporter.nih.gov
Developing a new platform to characterize and treat disease-associated polycystin variants	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$198,750	September 1, 2023	August 31, 2025	GUERRIERO, CHRISTOPHER JAMES	reporter.nih.gov
Metabolic imaging of hyperpolarized 13C pyruvate in polycystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2023	$193,617	September 1, 2022	June 30, 2025	MAYER, DIRK	reporter.nih.gov
Anandamide in blood pressure control	NIH	National Heart, Lung, and Blood Institute	2024 to 2025	$189,000	May 1, 2024	April 30, 2027	KLAWITTER, JELENA	reporter.nih.gov
Deciphering polycystin-dependent electric signaling of primary cilia in the renal system	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2023	$181,500	September 2, 2022	August 31, 2025	HA, KOTDAJI	reporter.nih.gov
Regulation of GLIS3, a Ciliary Transcription Factor that Prevents Kidney Cysts	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$176,244	June 15, 2025	March 31, 2030	LOEB, GABRIEL B	reporter.nih.gov
Impact of mitochondrial dynamics on the development of renal cysts in Tuberous Sclerosis Complex (TSC)	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$155,959	September 15, 2018	July 18, 2022	LAM, HILAIRE COLLETTA	reporter.nih.gov
Develop enabling biochemical and structural tools for dissecting the roles of PKD2L2 in metabolism	NIH	National Center for Advancing Translational Sciences	2022	$153,500	June 1, 2022	May 31, 2023	CAO, ERHU	reporter.nih.gov
Unraveling the Ciliary Driver of Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024	$142,902	September 1, 2024	July 31, 2029	VAN SCIVER, ROBERT E	reporter.nih.gov
Unraveling the Ciliary Driver of Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$141,402	September 1, 2024	August 31, 2029	VAN SCIVER, ROBERT E	reporter.nih.gov
Genetic dissection of fluid flow signaling in Left-Right patterning of zebrafish	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022 to 2024	$140,191	July 1, 2022	June 30, 2025	FISHER, KATHERINE H	reporter.nih.gov
Immune Cell and Epithelial Cell Interactions in Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023 to 2025	$137,809	September 1, 2023	May 15, 2026	RAI, VICTORIA	reporter.nih.gov
Constructing Mouse and Human Single-cell Atlas in Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024	$135,582	September 1, 2024	August 31, 2025	ZIMMERMAN, KURT A	reporter.nih.gov
Super-Resolution Deep Learning Framework for Enhanced ADPKD Monitoring via Multi-Sequence Longitudinal MRI	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$124,284	August 1, 2025	November 12, 2025	CHOOKHACHIZADEH MOGHADAM, MINA	reporter.nih.gov
Artificial Intelligence-Based Approaches for Renal Structure Characterization in Computed Tomography Images	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$119,250	August 1, 2020	October 31, 2022	KLINE, TIMOTHY LEE	reporter.nih.gov
Proteostatic regulation of disease-causing polycystin 2 variants	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$117,375	April 1, 2020	March 31, 2022	GUERRIERO, CHRISTOPHER JAMES	reporter.nih.gov
Elucidating the mechanisms of Glis3-regulated development in the pancreas and kidney	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$116,376	September 15, 2025	May 31, 2029	ZERUTH, GARY T	reporter.nih.gov
Advanced MR Imaging and Image Analytics as a Precision Medicine Tool to Manage ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$112,277	September 15, 2017	March 14, 2023	KLINE, TIMOTHY LEE	reporter.nih.gov
Metabolome and Microbiome Profiling in Response to Dietary Interventions in Patients with ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2023	$110,924	July 1, 2022	December 31, 2023	STEELE, CORTNEY NICOLE	reporter.nih.gov
Deregulation of Long Noncoding RNA in the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$108,526	May 15, 2019	March 31, 2025	ABOUDEHEN, KARAM	reporter.nih.gov
WNT signaling in Autosomal Dominant Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022 to 2024	$107,610	February 1, 2022	January 31, 2025	HARDY, EMILY P	reporter.nih.gov
Cyst induction and growth in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$100,000	September 15, 2021	September 14, 2023	CEBRIAN LIGERO, CRISTINA	reporter.nih.gov
MRI Risk Classification in Children and Young Adults with ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022	$100,000	September 15, 2022	September 14, 2024	CHAPMAN, ARLENE B	reporter.nih.gov
Mechanisms of Impaired Renal Hemodynamics after Spinal Cord Injury	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022	$100,000	September 21, 2022	September 20, 2023	OSEI-OWUSU, PATRICK	reporter.nih.gov
Discovering ADPKD Modifier Genes and Therapies via Zebrafish Genetics	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$100,000	September 20, 2023	September 19, 2025	XU, XIAOLEI	reporter.nih.gov
Circadian Clock Disruption in the Pathogenesis and Therapy of Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$99,998	September 15, 2021	March 14, 2023	RAO, REENA	reporter.nih.gov
Cellular Mechanisms of Renal Cystic Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2022	$99,977	September 21, 2022	June 30, 2023	LIEM, KAREL F	reporter.nih.gov
Utilization of Fasting Mimicking Diets to Treat and Prevent Clear Cell Renal Cell Carcinoma	NIH	National Cancer Institute	2022 to 2023	$95,946	August 1, 2022	February 29, 2024	MURPHY, SEAN	reporter.nih.gov
Mechanisms of cyst progression driven by Na,K-ATPase in autosomal dominant polycystic kidney disease (ADPKD).	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$77,593	August 4, 2024	August 3, 2028	TRANT, JORDAN	reporter.nih.gov
Polycystin glycosylation regulation and dysregulation in ADPKD	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024	$76,756	May 1, 2024	April 30, 2025	ESARTE PALOMERO, ORHI	reporter.nih.gov
Targeting kidney resident macrophage niche filling to slow cystic kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2024 to 2025	$64,886	May 1, 2024	December 18, 2025	YASHCHENKO, ALEX	reporter.nih.gov
Molecular Basis of Renal Epithelial Cell-Cell Adhesion	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021 to 2022	$62,484	April 1, 2020	August 31, 2022	VACHHARAJANI, VIPUL	reporter.nih.gov
Pharmacological inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR)	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$54,538	July 9, 2025	July 8, 2029	YOUNG, PAUL	reporter.nih.gov
How membrane lipids mediate ciliary signaling	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2025	$47,781	September 1, 2025	August 31, 2028	DERDERIAN, CAMILLE	reporter.nih.gov
High-throughput dissection of transcriptional regulation in kidney disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$38,721	September 1, 2020	August 31, 2022	TYCKO, JOSH	reporter.nih.gov
Roles for Pkd1l1 in bile duct development	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2023	$38,633	September 1, 2023	May 31, 2024	HELLEN, DOMINICK	reporter.nih.gov
Myosin Activation as a Novel Therapeutic Strategy for Polycystic Kidney Disease	NIH	National Institute of Diabetes and Digestive and Kidney Diseases	2021	$29,564	September 1, 2021	March 27, 2022	HELMS, LOUISA M	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
Mayo Clinic Rochester	Rochester, MN	12	$16.4 million	$0
Yale University	New Haven, CT	12	$13.7 million	$0
University of Maryland Baltimore	Baltimore, MD	6	$12.4 million	$0
University of Colorado Denver	Aurora, CO	10	$10.4 million	$0
University of Alabama at Birmingham	Birmingham, AL	7	$9.6 million	$0
Ut Southwestern Medical Center	Dallas, TX	5	$7 million	$0
University of Kansas Medical Center	Kansas City, KS	7	$6.2 million	$0
University of Washington	Seattle, WA	6	$5.9 million	$0
Brigham and Women's Hospital	Boston, MA	5	$5.4 million	$0
Icahn School of Medicine at Mount Sinai	New York, NY	2	$5.3 million	$0
SUNY at Stony Brook	Stony Brook, NY	5	$4.7 million	$0
University of California, San Francisco	San Francisco, CA	6	$4.6 million	$0
Rutgers University New Brunswick	New Brunswick, NJ	2	$4.5 million	$0
University of Oklahoma HLTH Sciences CTR	Oklahoma City, OK	7	$4.4 million	$0
Univ of Massachusetts Med SCH Worcester	Worcester, MA	2	$3.8 million	$0
Mayo Clinic Jacksonville	Jacksonville, FL	1	$3 million	$0
Northwestern University at Chicago	Chicago, IL	3	$2.8 million	$0
Johns Hopkins University	Baltimore, MD	2	$2.6 million	$0
University of Tennessee Health Sci CTR	Memphis, TN	1	$2.4 million	$0
University of California-Berkeley	Berkeley, CA	1	$2.1 million	$0
New York University School of Medicine	New York, NY	1	$2 million	$0
Sanford Research/usd	Sioux Falls, SD	1	$1.8 million	$0
University of California-Santa Barbara	Santa Barbara, CA	1	$1.8 million	$0
Methodist Hospital Research Institute	Houston, TX	1	$1.6 million	$0
Wayne State University	Detroit, MI	1	$1.6 million	$0
Massachusetts Eye and Ear Infirmary	Boston, MA	1	$1.6 million	$0
Children's Research Institute	Washington, DC	1	$1.6 million	$0
Cleveland Clinic Lerner Com-Cwru	Cleveland, OH	1	$1.5 million	$0
University of Utah	Salt Lake City, UT	2	$1.5 million	$0
University of Minnesota	Minneapolis, MN	3	$1.4 million	$0
University of California, San Diego	La Jolla, CA	1	$1.3 million	$0
Weill Medical Coll of Cornell Univ	New York, NY	4	$1.3 million	$0
Massachusetts General Hospital	Boston, MA	2	$1.3 million	$0
Seattle Children's Hospital	Seattle, WA	1	$1.3 million	$0
University of Toledo	Toledo, OH	1	$1.3 million	$0
Virginia Commonwealth University	Richmond, VA	1	$1.2 million	$0
Plurexa LLC	Seattle, WA	2	$1.1 million	$0
Emory University	Atlanta, GA	4	$1.1 million	$0
Cincinnati Childrens Hosp Med CTR	Cincinnati, OH	2	$1.1 million	$0
University of Pittsburgh at Pittsburgh	Pittsburgh, PA	3	$942,125	$0
University of Georgia Research Foundation Inc	Athens, GA	1	$906,000	$0
Stanford University	Stanford, CA	3	$873,532	$0
University of Arizona	Tucson, AZ	1	$600,159	$0
Vanderbilt University Medical Center	Nashville, TN	1	$537,861	$0
Michigan Technological University	Houghton, MI	1	$469,500	$0
University of Southern California	Los Angeles, CA	1	$465,690	$0
Dartmouth College	Hanover, NH	1	$410,000	$0
University of Iowa	Iowa City, IA	1	$396,609	$0
Pennsylvania State Univ University Park	University Park, PA	1	$379,212	$0
Broad Institute, Inc.	Cambridge, MA	1	$369,035	$0
Harvard Medical School	Boston, MA	1	$354,621	$0
Regennova, Inc.	Durham, NC	1	$349,325	$0
Western Michigan Univ School of Medicine	Kalamazoo, MI	1	$342,002	$0
Beth Israel Deaconess Medical Center	Boston, MA	1	$328,968	$0
Nephrogen Inc.	New York, NY	1	$325,000	$0
Inlighta Biosciences, LLC	Marietta, GA	1	$323,743	$0
Boston Children's Hospital	Boston, MA	1	$285,230	$0
Children's Hosp of Philadelphia	Philadelphia, PA	1	$252,386	$0
Oak Ridge Therapeutic Discovery (orrxd), LLC	Memphis, TN	1	$249,658	$0
University of California Los Angeles	Los Angeles, CA	1	$234,978	$0
University of Oregon Eugene	Eugene, OR	1	$140,191	$0
Murray State University	Murray, KY	1	$116,376	$0
University of Chicago	Chicago, IL	1	$100,000	$0
Case Western Reserve University	Cleveland, OH	1	$100,000	$0
University of Notre Dame	Notre Dame, IN	1	$95,946	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	64	$30,780,565	$0
2024	77	$32,503,690	$0
2023	84	$33,569,278	$0
2022	92	$34,347,541	$0
2021	83	$33,481,819	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)	PA-24-254	NIH		July 12, 2027	Not listed	Notice number printed on 2 awards here
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)	PA-24-182	NIH		May 8, 2027	Not listed	Notice number printed on 1 award here
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)	PA-24-191	NIH		May 7, 2027	Not listed	Notice number printed on 1 award here
Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)	RFA-DK-27-125	NIH	93.847	November 6, 2026	Not listed	Same assistance listing 93.847 as 140 awards here
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)	RFA-DK-27-112	NIH	93.847	November 9, 2026	Not listed	Same assistance listing 93.847 as 140 awards here
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)	RFA-DK-27-139	NIH	93.847	November 9, 2026	Not listed	Same assistance listing 93.847 as 140 awards here
Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)	RFA-DK-27-122	NIH	93.847	November 17, 2026	Not listed	Same assistance listing 93.847 as 140 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)	RFA-OD-24-011	NIH	93.847	December 4, 2026	Not listed	Same assistance listing 93.847 as 140 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)	PAR-27-039	NIH	93.847	January 5, 2027	Not listed	Same assistance listing 93.847 as 140 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)	PAR-25-379	NIH	93.847	January 7, 2027	Not listed	Same assistance listing 93.847 as 140 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)	RFA-NS-25-023	NIH	93.847	January 15, 2027	$350,000	Same assistance listing 93.847 as 140 awards here
Diabetes Research Centers (P30 Clinical Trial Optional)	RFA-DK-26-310	NIH	93.847	January 27, 2027	$1 million	Same assistance listing 93.847 as 140 awards here
NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional)	RFA-DK-28-114	NIH	93.847	January 28, 2027	Not listed	Same assistance listing 93.847 as 140 awards here
KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)	RFA-DK-28-312	NIH	93.847	January 30, 2027	Not listed	Same assistance listing 93.847 as 140 awards here
KUH U24 Center Coordinating Hub (U24 Clinical Trial Not Allowed)	RFA-DK-28-313	NIH	93.847	January 30, 2027	Not listed	Same assistance listing 93.847 as 140 awards here
Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)	RFA-DK-27-119	NIH	93.847	February 10, 2027	$750,000	Same assistance listing 93.847 as 140 awards here
Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)	RFA-DK-28-116	NIH	93.847	February 10, 2027	Not listed	Same assistance listing 93.847 as 140 awards here
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)	RFA-DK-27-108	NIH	93.847	March 10, 2027	$500,000	Same assistance listing 93.847 as 140 awards here
Single Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)	RFA-DK-28-115	NIH	93.847	March 10, 2027	Not listed	Same assistance listing 93.847 as 140 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.847	April 5, 2027	Not listed	Same assistance listing 93.847 as 140 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.